LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Results from molecular analysis for therapy choice (MATCH) arm I: Taselisib for PIK3CA-mutated tumors.

Photo by nci from unsplash

101Background: MATCH is a trial that assigns patients (pts) with solid tumors, lymphomas, or multiple myeloma to specific targeted therapies based on genetic alterations identified in fresh tumor b... Click to show full abstract

101Background: MATCH is a trial that assigns patients (pts) with solid tumors, lymphomas, or multiple myeloma to specific targeted therapies based on genetic alterations identified in fresh tumor b...

Keywords: analysis therapy; match; molecular analysis; therapy choice; choice match; results molecular

Journal Title: Journal of Clinical Oncology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.